Metabolic syndrome in patients with rheumatoid arthritis followed at a University Hospital in Northeastern Brazil

Revista Brasileira de Reumatologia

Volumn 56, Issue 2, 2016, Pages 117-125

  De Oliveira, Brenda Maria Gurgel Barreto ^a   Medeiros, Marta Maria das Chagas ^a   De Cerqueira, João Victor Medeiros ^b   Quixadá, Raquel Telles de Souza ^a   De Oliveira, Ídila Mont'Alverne Xavier ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b UNIVERSITY OF FORTALEZA   (Brazil)

Author keywords

Cardiovascular diseases; Metabolic syndrome; Rheumatoid arthritis

Indexed keywords

ABATACEPT; ADALIMUMAB; ETANERCEPT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; PREDNISONE; RITUXIMAB; SALAZOSULFAPYRIDINE;

ABDOMINAL OBESITY; ADULT; AGE; ARTICLE; BRAZIL; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; LABORATORY TEST; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OUTPATIENT; PREVALENCE; RHEUMATOID ARTHRITIS; SMOKING; TERTIARY CARE CENTER; UNIVERSITY HOSPITAL; MIDDLE AGED; BRAZILIAN;

AGE FACTORS; ARTHRITIS, RHEUMATOID; BRAZIL; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; METABOLIC SYNDROME; MIDDLE AGED; OBESITY, ABDOMINAL; SMOKING;

EID: 84982863624     PISSN: 04825004     EISSN: 18094570     Source Type: Journal    
DOI: 10.1016/j.rbre.2015.08.016     Document Type: Article

References (43)

1. Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, EsdaileJM, Lacaille D. Risk of cardiovascular mortality in patientswith rheumatoid arthritis: a meta-analysis of observationalstudies. Arthritis Rheum. 2008;59:1690-7.
2. Naranjo A, Sokka T, Descalzo MA, Calvo-Alén J, Hørslev-Petersen K, Luukkainen RK, et al. Cardiovasculardisease in patients with rheumatoid arthritis: results fromthe QUEST-RA study. Arthritis Res Ther. 2008;10:R30.
3. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascularevents and death: a systematic review and meta-analysis oflongitudinal studies. J Am Coll Cardiol. 2007;49:403-14.
4. Reaven G. The metabolic syndrome or the insulin resistancesyndrome? Different names, different concepts, anddifferents goals. Endocrinol Metab Clin N Am.2004;33:283-303.
5. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415-28.
6. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk: asystematic review and meta-analysis. J Am Coll Cardiol.2010;56:1113-32.
7. Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, et al. The metabolic syndrome as a predictor ofnonalcoholic fatty liver disease. Ann Intern Med.2005;143:722-70.
8. Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence andcharacteristics of the metabolic syndrome in women withpolycystic ovary syndrome. J Clin Endocrinol Metab.2005;90:1929-35.
9. Grundy SM. Cholesterol gallstones: a fellow traveler withmetabolic syndrome. Am J Clin Nutr. 2004;80:1-2.
10. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, WildingJP. Obstructive sleep apnoea is independently associated withna increased prevalence of metabolic syndrome. Eur Heart J.2004;25:735-41.
11. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, FonsecaV, et al. The metabolic syndrome and chronic kidney diseasein US adults. Ann Intern Med. 2004;140:167-74.
12. Choi HK, Ford ES, Li C, Curhan G. Prevalence of the metabolicsyndrome in patients with gout: the Third National Healthand Nutrition Examination Survey. Arthritis Care Res.2007;57:109-15.
13. Deissein PH, Tobias M, Veller MG. Metabolic syndrome andsubclinical atherosclerosis in rheumatoid arthritis. JRheumatol. 2006;33:2425-32.
14. Karvounaris SA, Sidiropoulos PI, Papadakis JA, Spanakis EK, Bertsias GK, Kritikos HD, et al. Metabolic syndrome iscommon among middle-to-older aged Mediterraneanpatients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study. Ann Rheum Dis. 2007;66:28-33.
15. La Montagna G, Cacciapuoti F, Buono R, Manzella D, MennilloGA, Arciello A, et al. Insulin resistance is an independent riskfactor for atherosclerosis in rheumatoid arthritis. DiabetesVasc Dis Res. 2007;4:130-5.
16. Chung CP, Oeser A, Solus JF, Avalos I, Gebretsadik T, ShintaniA, et al. Prevalence of the metabolic syndrome is increased inrheumatoid arthritis and is associated with coronaryatherosclerosis. Atherosclerosis. 2008;196:756-63.
17. Zonana-Nacach A, Santana-Sahagun E, Jimenez-Balderas FJ, Camargo-Coronel A. Prevalence and factors associated withmetabolic syndrome in patients with rheumatoid arthritisand systemic lupus erythematosus. J Clin Rheumatol.2008;14:74-7.
18. Toms TE, Panoulas VF, Douglas KMJ, Griffiths HR, Kitas GD. Lack of association between glucocorticoid use and presenceof the metabolic syndrome in patients with rheumatoidarthritis: a cross-sectional study. Arthritis Res Ther.2008;10:R145.
19. Elkan AC, Hakansson N, Frostegard J, Cederholm T, HafstromI. Rheumatoid cachexia is associated with dyslipidemia andlow levels of atheroprotective natural antibodies againstphosphorylcholine but not with dietary fat in patients withrheumatoid arthritis: a cross-sectional study. Arthritis ResTher. 2009;11:R37.
20. Giles JT, Allison M, Blumenthal RS, Post W, Gelber AC, Petri M, et al. Abdominal adiposity in rheumatoid arthritis. Association with cardiometabolic risk factors and diseasecharacteristics. Arthritis Rheum. 2010;62:3173-82.
21. Sahebari M, Goshayeshi L, Mirfeizi Z, Rezaieyazdi Z, Hatef MR, Ghayour-Mobarhan M, et al. Investigation of the associationbetween metabolic syndrome and disease activity inrheumatoid arthritis. Sci World J. 2011;11:1195-205.
22. Crowson CS, Myasoedova E, Davis JM, Matteson EL, Roger VL, Therneau TM, et al. Increased prevalence of metabolicsyndrome associated with rheumatoid arthritis in patientswithout clinical cardiovascular disease. J Rheumatol.2011;38:29-35.
23. Mok CC, Ko GTC, Ho LY, Yu KL, Chan PT, To CH. Prevalence ofatherosclerotic risk factors and the metabolic syndrome inpatients with chronic inflammatory arthritis. Arthritis CareRes. 2011;63:195-202.
24. Karimi M, Mazloomzadeh S, Kafan S, Amirmoghadami H. Thefrequency of metabolic syndrome in women with rheumatoidarthritis and in controls. Int J Rheum Dis. 2011;14:248-54.
25. da Cunha VR, Brenol CV, Brenol JCT, Fuchs SC, Arlindo EM, Melo IMF, et al. Metabolic syndrome prevalence is increasedin rheumatoid arthritis patients and is associated withdisease activity. Scand J Rheumatol. 2012;41:186-91.
26. Karakoc M, Batmaz I, Sariyildiz MA, Tahtasiz M, Cevik R, Tekbas E, et al. The relationship of metabolic syndrome withdisease activity and the functional status in patients withrheumatoid arthritis. J Clin Med Res. 2012;4:279-85.
27. Lee SG, Kim JM, Lee SH, Kim KH, Kim JH, Yi JW, et al. Is thefrequency of metabolic syndrome higher in South Koreanwomen with rheumatoid arthritis than in healthy subjects. Korean J Intern Med. 2013;28:206-15.
28. Rostom S, Mengat M, Lahlou R, Hari A, Bahiri R, Hajjaj-Hassouni N. Metabolic syndrome in rheumatoidarthritis: case control study. BMC Musculoskelet Disord.2013;14:147.
29. Salinas MJH, Bertoli AM, Lema L, Saucedo C, Rosa J, QuintanaR, et al. Prevalence and correlates of metabolic syndrome inpatients with rheumatoid arthritis in Argentina. J ClinRheumatol. 2013;19:439-43.
30. Pereira IA, Henrique da Mota LM, Cruz BA, Brenol CV, FronzaLSR, Bertolo MB, et al. Consenso 2012 da Sociedade Brasileirade Reumatologia sobre o manejo de comorbidades empacientes com artrite reumatoide. Rev Bras Reumatol.2012;52:474-95.
31. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association1987 revised criteria for the classification of rheumatoidarthritis. Arthritis Rheum. 1988;31:315-24.
32. Fraree Silva RL, Carmes ER, Scwartz AF, Blaszkowski DS, Cirino RHD, Ducci RDP. Cessação de tabagismo em pacientesde um hospital universitário em Curitiba. J Bras Pneumol.2011;37:480-7.
33. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van dePutte LB, van Riel PL. Modified disease activity scores thatinclude twenty-eight-joint counts. Development andvalidation in a prospective longitudinal study of patients withrheumatoid arthritis. Arthritis Rheum. 1995;38:44-8.
34. Ferraz MB, Oliveira LM, Araujo PM, Atra E, Tugwell P. Crosscultural reability of the physical ability dimension of theHealth Assessment Questionnaire. J Rheumatol.1990;17:813-7.
35. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of themetabolic syndrome. An American HeartAssociation/National Heart, Lung, and Blood InstituteScientific statement. Circulation. 2005;112:2735-52.
36. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome: a newworldwide definition. A consensus statement from theInternational Diabetes Federation. Diabet Med.2006;23:469-80.
37. Vidigal FC, Bressan J, Babio N, Salas-Savado J. Prevalence ofmetabolic syndrome in Brazilian adults: a systematic review. BMC Public Health. 2013;13:1198.
38. Stagakis I, Bertsias G, Karvounaris S, Kavousanaki M, Virla D, Raptopoulou A, et al. Anti-tumor necrosis factor therapyimproves insulin resistance, beta cell function and insulinsignaling in active rheumatoid arthritis patients with highinsulin resistance. Arthritis Res Ther. 2012;14:R141.
39. Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Llorca J. Insulin resistance inrheumatoid arthritis: the impact of the anti-TNF-alphatherapy. Ann N Y Acad Sci. 2010;1193:153-9.
40. Svenson KLG, Pollare T, Lithell H, Hallgren R. Impairedglucose handling in active rheumatoid arthritis: relationshipto peripheral insulin resistance. Metabolism. 1998;37:125-30.
41. Deissen PH, Joffe BJ, Stanwix AE, Christian BF, Veller M. Glucocorticoids and insulin sensitivity in rheumatoidarthritis. J Rheumatol. 2004;131:867-74.
42. Sun K, Liu J, Ning G. Active smoking and risk of metabolicsyndrome: a meta-analysis of prospective studies. PLoS ONE.2012;7:e47791.
43. Rabaeus M, Salen P, de Lorgeril M. Is it smoking or relatedlifestyle variables that increase metabolic syndrome risk? BMC Med. 2013;11:196.